Active Share (vs S&P 500): 87.6%
· vs QQQ: 86.9%
— share of the book that differs from index weights (higher = more active)
· ranking
In its Q3 2026 13F filing, Theleme Partners LLP disclosed 10 equity positions with a combined reported value of $2.62B. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q3 2026 were MRNA ($1.28B), META ($286.64M), AMZN ($227.38M). By sector, the heaviest allocations are Health Care 48.9%, Technology 18.7%. Versus the prior quarter, allocation shifted toward Health Care (+15.4pp), Technology (+2.0pp) and away from Real Estate (-2.5pp), Financials (-6.6pp).
Versus the prior quarter, Theleme Partners LLP opened 1 new positions, trimmed 2 and fully exited 0, a turnover rate of 30.0% of positions. The portfolio's overlap with the prior quarter was 90% of names.
The largest new positions opened in Q3 2026 were MSFT ($185.43M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
No tracked position was fully exited this quarter.
Insider Transactions (Form 4)
Latest Theleme Partners LLP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Theleme Partners LLP is an SEC-registered 13F filer. As of Q2 2026 it reported 9 US equity positions with a combined value of $1.68B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Portfolio Structure
9 positions · $1.68B reported value (Q2 2026)
Top 10 holdings = 100.0% of reported value
Largest position: MRNA (MODERNA INC) at 33.5%
Average position size: $187.05M
Sector Tilt
Health Care 33.5%
Consumer Discretionary 25.4%
Financials 18.0%
(classified holdings cover 100% of value)
Quarterly Activity
Q2 2026: 2 new, 4 added, 2 exited
3 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
AI Rebalance Analysis
1. Overall direction and market view: The fund reduced exposure to large-cap tech (META) and biotech (MRNA), added to cloud/tech (MSFT, AMZN), and increased financials (HDB, EFX), suggesting a rotation toward growth with select value plays and emerging markets.
2. Key moves:
- Reduced: MRNA (shares -17.4%), META (shares -14.0%).
- Added: MSFT (new position), AMZN (shares +10.9%), HDB (shares +95.3%), EFX (shares +7.3%).
- Held: UBER, TRU, EQIX, SIFY (no share changes).
3. Portfolio structure: Active, with a tilt toward Technology (48.9% top holding), Consumer Discretionary, and Financials; high concentration (top 3 = 67.5%) indicates aggressive risk appetite.
4. Per-holding one-liner:
- MRNA: mRNA vaccine developer (Moderna).
- META: Social media/tech (Meta Platforms).
- AMZN: E-commerce/cloud (Amazon).
- UBER: Ride-hailing/logistics (Uber).
- MSFT: Software/cloud (Microsoft).
- TRU: Credit reporting (TransUnion).
- EQIX: Data centers (Equinix).
- EFX: Credit reporting (Equifax).
- HDB: Indian banking (HDFC Bank).
- SIFY: Indian internet services (unverified).
5. Style summary: Rotated out of pandemic-era winners (MRNA, META) into cloud (MSFT, AMZN) and high-growth emerging markets (HDB), maintaining a concentrated, tech-biased portfolio.
Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-16 13:32
Every 13F share count is marked to the quarter-end close, rebuilding the NAV this
portfolio would have earned had it done nothing all quarter. This is a historical
reconstruction from already-public filings and prices — not a model forecast, so
precision/recall do not apply.
2023-Q3 = 100. Solid = reconstructed NAV, dashed = SPY benchmark.
Prices are split-adjusted closes and exclude dividends, so dividend-heavy
portfolios would in reality sit slightly above this line.
Forecast NAV for the next quarter (Top-10 weighted)
Not investment advice, and not the fund's real NAV
The daily curve weights only the model's predicted Top-10, i.e. about 99.9% of
reported value; the remainder is treated as cash (zero return). It mirrors what the fund holds,
not stock-picking skill — a concentrated book can put 40%+ in one name and will swing far more than an index.
The holdings forecast backtests at F1 84% for this fund with
~16% quarterly Top-10 turnover; the higher that turnover, the less
this curve is worth reading.
Not actionable
Actionable
Start 2026-06-30Filed 2026-08-13Today 2026-10-30
2026-06-30 = 100 (end of 2026-Q2).
The stretch up to 2026-08-13 uses holdings only known on the filing date and was
not actionable in real time; only the part after it could be traded.
Since start
+26.0%/ SPY +4.4%
Since filing (actionable)
+21.3%
Missing prices
16.6%
Largest position
33.3%
Source: full 13F positions marked to quarter-end closes (computed 2026-11-02 01:13:11).
Share counts and prices are used as a ratio, so splits cancel out.
Holdings Prediction Model
Predicts next-quarter Top-10 holdings and weights from the fund's own historical
trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative
volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through
quarter T. Weights are shares of the modelled portfolio.
The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.
MRNA · WFC · META · TRU · FLUT · BAC · UBER · EFX · AMZN · HDB
2025-Q3
90%
90%
90%
MRNA · WFC · FLUT · META · TRU · UBER · BAC · EFX · AMZN · HDB
META · WFC · MRNA · TRU · UBER · FLUT · EFX · AMZN · BAC · SIFY
2025-Q4
90%
100%
95%
META · WFC · MRNA · TRU · UBER · FLUT · EFX · AMZN · BAC · SIFY
META · MRNA · FLUT · TRU · WFC · UBER · AMZN · EFX · SIFY
2026-Q1
89%
89%
89%
META · MRNA · FLUT · TRU · WFC · UBER · AMZN · EFX · SIFY
MRNA · META · UBER · TRU · AMZN · FLUT · EFX · HOOD · SIFY
2026-Q2
78%
78%
78%
MRNA · META · UBER · TRU · AMZN · FLUT · EFX · HOOD · SIFY
MRNA · META · UBER · AMZN · TRU · EQIX · EFX · HDB · SIFY
2026-Q3 ★
100%
90%
95%
MRNA · META · UBER · AMZN · TRU · EQIX · EFX · HDB · SIFY
MRNA · META · AMZN · UBER · MSFT · TRU · EQIX · EFX · HDB · SIFY
★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.
Barra Factor Attribution
The disclosed long US equity book from the 2026-Q3 13F is held at its
report-date weights and decomposed over 2026-09-30 ~ 2026-11-13.
The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional
factor returns and an EWMA factor covariance for risk. The “portfolio” is the
visible 13F book, not the fund's true NAV.
The quarter is not complete yet; the window ends at the latest available price date, 2026-11-13, and will update as prices arrive.
Portfolio return+9.79%Buy & hold
QQQ synthetic benchmark-13.72%Liquidity weighted
Excess return+23.51%vs benchmark
Barra annualised vol50.1%Model estimate
Realised vol60.2%Annualised in window
Weighted beta1.61Raw exposure
Factor / specific risk50% / 50%Share of variance
Top-10 concentration100.0%Of reported value
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.
1. Performance
Metric
Value
Note
Portfolio return (buy & hold)
+9.79%
Disclosed long book
QQQ synthetic benchmark
-13.72%
Liquidity-weighted constituents
Model universe, equal weight
+0.30%
Opportunity-cost reference
Excess return
+23.51%
Portfolio − benchmark
Arithmetic return sum
+11.60%
Difference vs compounded is the cross term
Weighted raw beta
1.61
Weighted holding betas
Realised volatility (annualised)
60.20%
Daily returns in window
Barra model volatility (annualised)
50.09%
Factor + specific
Factor share of variance
50.0%
Barra factors
Specific share of variance
50.0%
Stock residuals
Reported value
$2.38B
13F long US equity
2. Return attribution
The +11.60% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.
Factor group
Factors
Contribution
Share of |return|
Size & Liquidity
6
-0.73%
-6.3%
Momentum & Growth
3
-3.58%
-30.9%
Volatility & Tail Risk
7
-13.51%
-116.5%
Industry
12
+5.38%
46.4%
Specific
1
+24.03%
207.3%
Factor
Type
Exposure
Factor return
Contribution
Share of |return|
Specific
Specific
—
—
+24.03%
207.3%
Kurtosis
Style
+2.51
+6.97%
+17.52%
151.1%
Health Care
Industry
+0.54
+8.12%
+4.38%
37.8%
Beta
Style
+0.77
+4.85%
+3.74%
32.2%
Growth
Style
+2.15
+1.57%
+3.37%
29.1%
Leverage (Downside Vol)
Style
-1.21
-1.82%
+2.20%
19.0%
Consumer Discretionary
Industry
+0.19
+7.85%
+1.48%
12.7%
Turnover
Style
-0.31
-4.77%
+1.47%
12.7%
Liquidity
Style
+1.53
+0.22%
+0.33%
2.9%
Real Estate
Industry
+0.04
+5.90%
+0.27%
2.3%
Non-linear Size
Style
+0.23
+0.91%
+0.21%
1.8%
Mid Cap
Style
+0.15
-1.69%
-0.25%
-2.2%
Amihud Illiquidity
Style
+1.67
-0.40%
-0.67%
-5.8%
Information Technology
Industry
+0.20
-3.57%
-0.71%
-6.1%
Short-term Reversal
Style
-1.01
+0.79%
-0.80%
-6.9%
Max Drawdown
Style
+0.83
-1.96%
-1.63%
-14.1%
Size
Style
+0.99
-1.83%
-1.81%
-15.6%
Residual Volatility
Style
-1.75
+2.66%
-4.66%
-40.2%
Momentum
Style
+1.85
-3.34%
-6.16%
-53.1%
Skewness
Style
+1.93
-4.21%
-8.15%
-70.3%
Historical Volatility
Style
+1.75
-12.86%
-22.51%
-194.2%
3. Risk attribution
Annualised volatility is 50.09%; factor risk explains 50.0% of variance and specific risk 50.0%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.
Factor
Type
Exposure
Share of variance
Vol contribution
Share of vol
Specific
Specific
—
50.0%
+25.06%
25.1%
Growth
Style
+2.15
11.3%
+5.66%
5.7%
Momentum
Style
+1.85
9.0%
+4.50%
4.5%
Historical Volatility
Style
+1.75
8.9%
+4.47%
4.5%
Beta
Style
+0.77
7.8%
+3.89%
3.9%
Health Care
Industry
+0.54
5.5%
+2.78%
2.8%
Kurtosis
Style
+2.51
2.9%
+1.46%
1.5%
Liquidity
Style
+1.53
2.2%
+1.10%
1.1%
Leverage (Downside Vol)
Style
-1.21
1.9%
+0.96%
1.0%
Information Technology
Industry
+0.20
1.9%
+0.94%
0.9%
Amihud Illiquidity
Style
+1.67
1.6%
+0.78%
0.8%
Consumer Discretionary
Industry
+0.19
1.4%
+0.73%
0.7%
Max Drawdown
Style
+0.83
1.4%
+0.70%
0.7%
Real Estate
Industry
+0.04
0.6%
+0.29%
0.3%
Financials
Industry
+0.03
0.3%
+0.13%
0.1%
Turnover
Style
-0.31
-0.2%
-0.11%
-0.1%
Non-linear Size
Style
+0.23
-0.3%
-0.14%
-0.1%
Short-term Reversal
Style
-1.01
-1.6%
-0.81%
-0.8%
Skewness
Style
+1.93
-1.9%
-0.94%
-0.9%
Residual Volatility
Style
-1.75
-2.5%
-1.26%
-1.3%
4. Style exposures
Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.
Style factor
Portfolio
QQQ benchmark
Difference
Size
+0.99
+2.10
-1.11
Non-linear Size
+0.23
+1.68
-1.45
Mid Cap
+0.15
+0.13
+0.02
Beta
+0.77
+1.29
-0.52
Momentum
+1.84
+0.72
+1.13
Short-term Reversal
-1.01
-0.64
-0.37
Residual Volatility
-1.75
-0.40
-1.35
Historical Volatility
+1.75
+0.86
+0.89
Liquidity
+1.53
+0.11
+1.42
Amihud Illiquidity
+1.67
+1.16
+0.51
Turnover
-0.31
+0.21
-0.52
Growth
+2.15
+0.58
+1.57
Leverage (Downside Vol)
-1.21
+0.14
-1.35
Skewness
+1.94
+0.24
+1.70
Kurtosis
+2.51
+0.21
+2.30
Max Drawdown
+0.83
-0.08
+0.92
5. Industry allocation & Brinson
Sector
Portfolio
Benchmark
Portfolio ret
Benchmark ret
Allocation
Selection
Interaction
Total
Information Technology
19.9%
73.6%
-6.15%
-19.18%
+3.16%
+9.60%
-7.01%
+12.90%
Health Care
54.0%
1.7%
+15.99%
+9.16%
+11.74%
+0.12%
+3.57%
+8.48%
Financials
2.9%
0.0%
+15.62%
+0.00%
+0.38%
+0.00%
+0.45%
+0.45%
Communication Services
0.0%
2.6%
+0.00%
-15.54%
+0.06%
+0.41%
-0.41%
+0.41%
Consumer Discretionary
18.8%
8.8%
+4.42%
+5.56%
+1.88%
-0.10%
-0.11%
+0.34%
Real Estate
4.5%
0.0%
+4.17%
+0.00%
+0.60%
+0.00%
+0.19%
+0.19%
Utilities
0.0%
0.8%
+0.00%
+11.58%
-0.20%
-0.09%
+0.09%
-0.09%
Consumer Staples
0.0%
0.8%
+0.00%
+15.58%
-0.24%
-0.13%
+0.13%
-0.13%
Industrials
0.0%
11.1%
+0.00%
+7.16%
-2.27%
-0.80%
+0.80%
-0.80%
Total
+15.00%
+8.96%
-2.27%
+21.70%
6. Holdings & contribution
Symbol
Name
Sector
Weight
Return
Contribution
QoQ
MRNA
MODERNA INC
Health Care
53.98%
+15.99%
+8.63%
Reduce
META
META PLATFORMS INC
Information Technology
12.07%
-11.51%
-1.39%
Reduce
AMZN
AMAZON COM INC
Consumer Discretionary
9.57%
+7.03%
+0.67%
Add
UBER
UBER TECHNOLOGIES INC
Consumer Discretionary
9.22%
+1.72%
+0.16%
Hold
MSFT
MICROSOFT CORP
Information Technology
7.81%
+2.14%
+0.17%
New
EQIX
EQUINIX INC
Real Estate
4.50%
+4.17%
+0.19%
Hold
HDB
HDFC BANK LTD
Financials
2.86%
+15.62%
+0.45%
Add
Contribution rank
Symbol
Sector
Weight
Return
Contribution
1
MRNA
Health Care
53.98%
+15.99%
+8.63%
2
AMZN
Consumer Discretionary
9.57%
+7.03%
+0.67%
3
HDB
Financials
2.86%
+15.62%
+0.45%
4
EQIX
Real Estate
4.50%
+4.17%
+0.19%
5
MSFT
Information Technology
7.81%
+2.14%
+0.17%
6
UBER
Consumer Discretionary
9.22%
+1.72%
+0.16%
7
META
Information Technology
12.07%
-11.51%
-1.39%
7. Conclusions
Over the attribution window 2026-09-30 → 2026-11-13 (32 trading days), the reported portfolio returned +9.79%, versus -13.72% for the QQQ synthetic benchmark — an excess of +23.51%.
Return attribution: the largest positive style/industry contributions came from Kurtosis +17.52%, Health Care +4.38%, Beta +3.74%; the largest drags came from Historical Volatility -22.51%, Skewness -8.15%, Momentum -6.16%. Specific (stock-level) return contributed +24.03%.
Risk attribution: Barra model volatility is 50.09% annualised; factor risk explains 50% of variance and specific risk 50%. The largest factor risk sources are Growth 11.3%, Momentum 9.0%, Historical Volatility 8.9%.
Style tilt: size +0.99, momentum +1.84, volatility +1.75, liquidity +1.53; the weighted raw beta is 1.61. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
Industry: the largest overweight versus the benchmark is Health Care (+52.2 pp), the largest underweight is Information Technology (-53.8 pp). Allocation contributed +15.00%, selection +8.96% and interaction -2.27%.
Concentration: the top-10 positions are 100.0% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.
FAQ
What did Theleme Partners LLP buy in 2026-Q3?
In its 2026-Q3 13F filing, Theleme Partners LLP reported 10 equity positions worth $2.62B in aggregate; its largest disclosed positions were MRNA ($1.28B), META ($286.64M), AMZN ($227.38M).
How large is Theleme Partners LLP's portfolio?
Theleme Partners LLP reported $2.62B of long equity holdings across 10 positions as of 2026-Q3. Top-10 holdings account for 100.0% of reported value.
What is Theleme Partners LLP's investment style?
HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.
Embed this fund on your site
Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.
<iframe src="https://holdingshub.top/funds/theleme-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>